Glucocorticoids (GC) are an important risk factor for bone fragility in children with serious
illnesses, largely due to their direct adverse effects on skeletal metabolism. To better …

Background Children with chronic illnesses are at increased risk for reductions in bone
strength and subsequent fractures (osteoporosis), either due to the impact of the underlying …

STUDY OBJECTIVE: To assess feasibility, and collect preliminary data for a subsequent
randomized, sham-controlled trial to evaluate Japanese-style acupuncture for reducing …

Glucocorticoids (GC) are used in almost all medical specialties, and approximately 0.5% of
the general population of the United Kingdom receives those medications. With the …

Abstract Context Glucocorticoids (GCs) prescribed for chronic pediatric illnesses are
associated with osteoporotic fractures. Objective This study aims to determine the efficacy …

The Brazilian guidelines for prevention and treatment of glucocorticoid-induced
osteoporosis were updated and important topics were included such as assessment of risk …

Background Children and young people (CYP) with chronic rheumatic conditions; Juvenile
Idiopathic Arthritis, Juvenile Systemic Lupus Erythematosus, Juvenile Dermatomyositis and …

Animal models have aided our understanding of the pathophysiology and treatment of
osteoporosis. They have been an especially useful tool for investigating interactions …

More than 70 years ago, osteoporosis associated with endogenous glucocorticoid excess
was described by Harvey Cushing. More common is the increased fracture risk associated …

Aims The aim of this systematic review was to evaluate, critically, the treatment options used
in the management of bone loss associated with glucocorticoid (GC) use among children …